Literature DB >> 19837765

99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.

Enrico Saggiorato1, Tiziana Angusti, Rosy Rosas, Morena Martinese, Monica Finessi, Federico Arecco, Edoardo Trevisiol, Nicoletta Bergero, Barbara Puligheddu, Marco Volante, Valerio Podio, Mauro Papotti, Fabio Orlandi.   

Abstract

UNLABELLED: Recently, thyroid (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) scintiscanning has been proposed in an attempt to preoperatively identify thyroid malignancies, but discrepant results have been reported for oncocytic lesions. The aim of this study was to investigate the usefulness of visual and semiquantitative analyses of (99m)Tc-MIBI scintigraphy for preoperatively characterizing thyroid nodules with indeterminate cytologic diagnoses, segregating in advance nononcocytic variants from those that are oncocytic. This study also aimed to analyze the relationship between (99m)Tc-MIBI images and P-glycoprotein (P-gp)/multidrug resistance-associated protein-1 (MRP1) immunohistochemical expression.
METHODS: Fifty-one consecutive patients with cold thyroid nodules cytologically diagnosed as nononcocytic or oncocytic follicular neoplasm were prospectively studied. Visual and semiquantitative (99m)Tc-MIBI scanning was performed and the diagnoses of the lesions were histologically proven by subsequent thyroidectomy. Immunohistochemical evaluation of P-gp and MRP1 was also performed on surgical samples.
RESULTS: Visual and semiquantitative (99m)Tc-MIBI scintiscans showed a low specificity in preoperatively discriminating malignant oncocytic lesions. In nononcocytic nodules, the semiquantitative method was more accurate than the visual (94.44% and 77.78%, respectively). P-gp protein expression was negative in all thyroid lesions, whereas apical plasma membrane MRP1 expression was found in 78% of the lesions with a negative (99m)Tc-MIBI retention index, compared with 11% of lesions with a positive retention index, correlating most strongly with a negative (99m)Tc-MIBI RI in those cases with strong MRP1 apical expression.
CONCLUSION: Semiquantitative (99m)Tc-MIBI scintigraphy is an adjunctive method to predict preoperatively the malignant behavior of nononcocytic follicular thyroid nodules indeterminate at fine-needle aspiration biopsy, with a potential impact on the definition of their clinical management. Moreover, the good correlation found between immunohistochemical apical expression of MRP1 and the scintigraphic findings supports the (99m)Tc-MIBI results and provides tissue information on the molecular mechanisms responsible for (99m)Tc-MIBI images in thyroid lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837765     DOI: 10.2967/jnumed.109.064980

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis.

Authors:  Giorgio Treglia; Carmelo Caldarella; Enrico Saggiorato; Luca Ceriani; Fabio Orlandi; Massimo Salvatori; Luca Giovanella
Journal:  Endocrine       Date:  2013-03-26       Impact factor: 3.633

2.  99mTc-MIBI imaging in thyroid nodules: is it useful?

Authors:  Raffaele Giubbini; Francesco Bertagna
Journal:  Endocrine       Date:  2014-02-28       Impact factor: 3.633

3.  Clinical Utility of Tc-99m MIBI SPECT/CT for Preoperative Localization of Parathyroid Lesions.

Authors:  Zeynep Gozde Ozkan; Seher Nilgun Unal; Serkan Kuyumcu; Yasemin Sanli; Mehmet Fatih Gecer; Beyza Ozcinar; Yasemin Senyurek Giles; Yesim Erbil
Journal:  Indian J Surg       Date:  2016-05-04       Impact factor: 0.656

4.  Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients.

Authors:  Kenkichi Baba; Masatoshi Ishibashi; Hayato Kaida; Teruhiko Fujii; Yuji Hiromatsu; Akihiko Kawahara; Masayoshi Kage; Naofumi Hayabuchi
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

5.  Reliability of real-time elastography to diagnose thyroid nodules previously read at FNAC as indeterminate: a meta-analysis.

Authors:  Pierpaolo Trimboli; Giorgio Treglia; Ramin Sadeghi; Francesco Romanelli; Luca Giovanella
Journal:  Endocrine       Date:  2014-12-23       Impact factor: 3.633

Review 6.  Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis.

Authors:  Pierpaolo Trimboli; Giorgio Treglia; Leo Guidobaldi; Enrico Saggiorato; Giuseppe Nigri; Anna Crescenzi; Francesco Romanelli; Fabio Orlandi; Stefano Valabrega; Ramin Sadeghi; Luca Giovanella
Journal:  Endocrine       Date:  2013-10-03       Impact factor: 3.633

7.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Anita Wale; Kenneth A Miles; Barnaby Young; Charles Zammit; Anthony Williams; John Quin; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

8.  Semi-quantitative analysis of 99mTc-sestamibi retention level for preoperative differential diagnosis of parathyroid carcinoma.

Authors:  Min Zhang; Lihao Sun; Weiwei Rui; Rui Guo; Huihui He; Ying Miao; Hongping Meng; Jianmin Liu; Biao Li
Journal:  Quant Imaging Med Surg       Date:  2019-08

9.  18F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study.

Authors:  Renaud Ciappuccini; Idlir Licaj; Audrey Lasne-Cardon; Emmanuel Babin; Dominique de Raucourt; David Blanchard; Vianney Bastit; Virginie Saguet-Rysanek; Justine Lequesne; Damien Peyronnet; Jean-Michel Grellard; Bénédicte Clarisse; Stéphane Bardet
Journal:  Thyroid       Date:  2020-12-23       Impact factor: 6.568

Review 10.  Imaging of multidrug resistance in cancer.

Authors:  S Dizdarevic; A M Peters
Journal:  Cancer Imaging       Date:  2011-03-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.